Inappropriate retinoic acid receptor-β expression in oral dysplasias: Correlation with acquisition of the immortal phenotype

Cancer Research

Volumn 57, Issue 18, 1997, Pages 3886-3889

  McGregor, Fiona ^a   Wagner, Eric ^a   Felix, David ^c   Soutar, David ^b   Parkinson, Kenneth ^a   Harrison, Paul R ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b CANNIESBURN PLASTIC SURGERY UNIT   (United Kingdom)

^c GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID RECEPTOR;

ARTICLE; CANCER CELL; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL TRANSFORMATION; CHEEK MUCOSA; DYSPLASIA; HUMAN; HUMAN CELL; KERATINIZATION; MOUTH MUCOSA; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL;

CARRIER PROTEINS; CELL DIVISION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOUTH MUCOSA; MOUTH NEOPLASMS; PHENOTYPE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, RETINOIC ACID; RNA, MESSENGER; RNA, NEOPLASM; TONGUE;

EID: 0030882426     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hong, W. K., Endocott, J., Itri, L. M., Doos, W., Batsakis, J. G., Bell, R., Fofonoff, S., Byers, R., Atkinson, E. N., Vaughan, C., Toth, B. B., Kramer, A., Dimery, I. W., Skipper, P., and Strong, S. 13-cis-Retinoic acid in the treatment of oral leukoplakia. N. Engl. J. Med., 315: 1501-1505, 1986.
2. Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., Dimery, I. W., Brown, B. W., and Goepfert, H. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 323: 795-801, 1990.
3. Xu, X-C., Ro, J. Y., Lee, J. S., Shin, D. M., Hong, W. K., and Lotan, R. Differential expression of nuclear retinoid receptors in normal, premalignant and malignant head and neck tissues. Cancer Res., 54: 3580-3587, 1994.
4. Hu, L., Crowe, D. L., Rheiwald, J. G., Chambon, P., and Gudas, L. Abnorma expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res., 51: 3972-3981, 1991.
5. Crowe, D. L., Hu, L., Guda, L. J., and Rheinwald, J. G. Variable expression of retinoic acid receptor (RARβ) mRNA in human oral and epidermal keratinocytes: relation to keratin 19 expression and keratinization potential. Differentiation, 48: 199-208, 1991.
6. Lotan, R., Xu, X-C., Lippman, S. M., Ro, J. Y., Lee, J. S., Lee, J. J., and Hong, W. K. Suppression of retinoic acid receptor-β in premalignant oral lesions and its up-regulation by isotretinoin. N. Engl. J. Med., 332: 1405-1410, 1995.
7. Xu, X-C., Sozzi, G., Lee, J. S., Lee, J. J., Pastorino, U., Pilotti, S., Kurie, J. M., Hong, W. K., and Lotan, R. Suppression of retinoic acid receptor β in non-small-cell lung cancer in vivo: implications for lung cancer development. J. Natl. Cancer Inst., 89: 624-629, 1997.
8. Swisshelm, K., Ryan, K., Lee, X., Tsou, H. C., Peacocke, M., and Sager, R. Down-regulanon of retinoic acid receptor β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differ., 5: 133-141, 1994.
9. Geisen, C., Denk, C., Gremm, B., Baust, C., Karger, A., Bollag, W., and Schwarz, E. High-level expression of the retinoic acid receptor β gene in normal cells of the uterine cervix is regulated by the retinoic acid receptor α and is abnormally down-regulated in cervical carcinoma cells. Cancer Res., 57: 1460-1467, 1997.
10. Caliaro, M. J., Marmouget, C., Guichard, S., Mazars, P., Valette, A., Moisand, A., Bugat, R., and Jozan, S. Response of four human ovarian carcinoma cell lines to all-trans retinoic acid: relationship with induction of differentiation and retinoic acid receptor expression. Int. J. Cancer, 56: 743-748, 1994.
11. Houle, B., Rochette-Egly, C., and Bradley, W. E. C. Tumor-suppress effect of the retinoic acid receptor β in human epidermoid lung cancer cells. Proc. Natl. Acad. Sci. USA, 90: 985-989, 1993.
12. Lotan, R. Retinoids and their receptors in modulation of differentiation, development and prevention of head and neck cancers. Anticancer Res., 16: 2415-2420, 1996.
13. Edington, K. G., Loughran, O. P., Berry, I. J., and Parkinson, E. K. Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with P53 alteration and a high frequency of allele loss. Mol. Carcinog., 13: 254-265, 1995.
14. Marais, R., Wynne, J., and Treisman, R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell, 73: 381-393, 1993.
15. Barrett, M. T., Sanchez, C. A., Galipeau, P. C., Neshat, K., Emond, M., and Reid, B. J. Allelic loss of 9p21 and mutation of the CDKNa/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene, 13: 1867-1873, 1996.
16. Timmermann, S., Hinds, P. W., and Munger, K. Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines. Cell Growth Differ., 8: 361-370, 1997.
17. ink4a in oral premalignant lesions. Oncogene, 14: 1799-1803, 1997.
18. Reed, A. L., Califana, J., Cairns, P., Westra, W. H., Jones, R. M., Koch, W., Ahrendt, S., Eby, Y., Sewell, D., Nawroz, H., Bartek, J., and Sidransky, D. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res., 56: 3630-3633, 1996.
19. ink4a with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene, 13: 561-568, 1996.